U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Benchmark upgraded Meta Platforms (META) to Buy from Hold with a $820 price target, citing a "strong" 2025 core business ...
Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration has approved JOURNAVX, an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor ...
EST Vertex Pharmaceuticals (VRTX)’ non-opioid painkiller approved by FDA, Bloomberg saysInvest with Confidence: Follow TipRanks' Top Wall ...
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...
The benchmark U.S. 10-year Treasury yield (US10Y) dipped below 4.50% for the first time in over a month, after the Fed's ...
Gold prices hit record highs on safe-haven demand, weaker dollar, and low yields. Some analysts forecast gold rising to $3,000 in the short term.
Suki, the leader in artificial intelligence (AI) technology for healthcare, today announced an investment from Zoom Ventures, the investment arm of the AI-first work platform and leading healthcare ...